or
forgot password

    • cancer clinical trials in springfield, MA

    • Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Baystate Medical Center
    Springfield, Massachusetts 01199
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    Red Cell Storage Duration Study
    Baystate Medical Center
    Springfield, Massachusetts 01199
    Cardiac Surgery, Erythrocyte Transfusion
    Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
    Baystate Regional Cancer Program at D'Amour Center for Cancer Care
    Springfield, Massachusetts 01199
    Leukemia
    Investigate Safety, Pharmacokinetics and Pharmacodynamics of GSK2118436 & GSK1120212
    GSK Investigational Site
    Springfield, Massachusetts 01107
    Cancer
    Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
    Baystate Regional Cancer Program at D'Amour Center for Cancer Care
    Springfield, Massachusetts 01199
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II, Stage III, Stage IV, or Recurrent Stage I Epithelial Ovarian Cancer or Fallopian Tube Cancer
    Baystate Medical Center
    Springfield, Massachusetts 01199
    Ovarian Mucinous Cystadenocarcinoma, Ovarian Mucinous Cystadenoma With Proliferating Activity, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Stage IA Fallopian Tube Cancer, Stage IA Ovarian Epithelial Cancer, Stage IB Fallopian Tube Cancer, Stage IB Ovarian Epithelial Cancer, Stage IC Fallopian Tube Cancer, Stage IC Ovarian Epithelial Cancer, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer
    Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer
    Baystate Regional Cancer Program at D'Amour Center for Cancer Care
    Springfield, Massachusetts 01199
    Cervical Cancer, Endometrial Cancer, Sarcoma
    Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
    Baystate Regional Cancer Program at D'Amour Center for Cancer Care
    Springfield, Massachusetts 01199
    Lung Cancer
    EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Baystate Regional Cancer Program at D'Amour Center for Cancer Care
    Springfield, Massachusetts 01199
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Carcinoma
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    Baystate Regional Cancer Program at D'Amour Center for Cancer Care
    Springfield, Massachusetts 01199
    Kidney Cancer
    First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers
    Local Institution
    Springfield, Massachusetts
    Acute Myelogenous Leukemia, Diffuse Large B-Cell Leukemia, Chronic Lymphocytic Leukemia, Follicular Lymphoma
    Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
    Baystate Regional Cancer Program at D'Amour Center for Cancer Care
    Springfield, Massachusetts 01199
    Colorectal Cancer
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Baystate Medical Center
    Springfield, Massachusetts 01199
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    A Study of Chemotherapy and Ramucirumab vs. Chemotherapy Alone in Second Line Non-small Cell Lung Cancer Participants Who Received Prior First Line Platinum Based Chemotherapy
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Springfield, Massachusetts
    Non Small Cell Lung Cancer
    Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
    D'Amour Center for Cancer Care
    Springfield, Massachusetts 01107
    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Stage IB Esophageal Cancer, Stage IIA Esophageal Cancer, Stage IIB Esophageal Cancer, Stage IIIA Esophageal Cancer, Stage IIIB Esophageal Cancer
    Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Clear Cell Ovarian Cancer
    Baystate Medical Center
    Springfield, Massachusetts 01199
    Ovarian Clear Cell Cystadenocarcinoma, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
    Baystate Medical Center
    Springfield, Massachusetts 01199
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    A Study in Patients With Rheumatoid Arthritis
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Springfield, Massachusetts
    Rheumatoid Arthritis
    A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
    GSK Investigational Site
    Springfield, Massachusetts 01107
    Cancer
    GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma
    GSK Investigational Site
    Springfield, Massachusetts 01107
    Melanoma
    A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Springfield, Massachusetts
    Stomach Cancer, Esophageal Cancer
    Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer
    Baystate Medical Center
    Springfield, Massachusetts 01199
    Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer, Stage III Prostate Cancer
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Baystate Medical Center
    Springfield, Massachusetts 01199
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    A Study of Anti-VEGFR-3 Monoclonal Antibody IMC-3C5 in Subjects With Advanced Solid Tumors
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Springfield, Massachusetts
    Neoplasms
    A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
    DM Clinical Research
    Springfield, Massachusetts 01103
    Overactive Bladder
    A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
    GSK Investigational Site
    Springfield, Massachusetts 01107
    Infection, Human Immunodeficiency Virus
    Study of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure
    Baystate Critical Care Medicine / Tufts University School of Medicine
    Springfield, Massachusetts 01199
    Acute Lung Injury, Acute Respiratory Distress Syndrome, Respiratory Failure
    Comparative Effectiveness Multicenter Trial for Adhesion Characteristics of Ventral Hernia Repair Mesh
    Baystate Medical Center
    Springfield, Massachusetts 01199
    Ventral Hernia, Adhesions
    An Open-label Study of GSK1120212 Compared With Docetaxel in Stage IV KRAS-mutant Non-small Cell Lung Cancer
    GSK Investigational Site
    Springfield, Massachusetts 01107
    Lung Cancer, Non-Small Cell
    Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
    Baystate Regional Cancer Program at D'Amour Center for Cancer Care
    Springfield, Massachusetts 01199
    Anxiety Disorder, Fallopian Tube Cancer, Fatigue, Nausea and Vomiting, Neurotoxicity, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer
    Baystate Regional Cancer Program at D'Amour Center for Cancer Care
    Springfield, Massachusetts 01199
    Cervical Cancer, Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Sexuality and Reproductive Issues
    Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
    Local Institution
    Springfield, Massachusetts
    Leukemia, Pediatric
    Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
    Baystate Medical Center
    Springfield, Massachusetts 01199
    Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    Observation in Patients With Early-Stage Vulvar Cancer Following Surgery and/or Radiation Therapy
    Baystate Regional Cancer Program at D'Amour Center for Cancer Care
    Springfield, Massachusetts 01199
    Long-term Effects Secondary to Cancer Therapy in Adults, Vulvar Cancer
    Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
    Baystate Medical Center
    Springfield, Massachusetts 01199
    Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Refractory Anemia With Excess Blasts, Secondary Myelodysplastic Syndromes
    Continuation Study of the Oral AKT Inhibitor GSK2110183
    GSK Investigational Site
    Springfield, Massachusetts 01107
    Cancer
    A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Springfield, Massachusetts
    Neoplasms, Hematologic
    A Study of Tabalumab in Participants With Previously Treated Multiple Myeloma (MM)
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Springfield, Massachusetts
    Multiple Myeloma
    Study of BMS-936558 Compared to Docetaxel in Previously Treated Advanced or Metastatic Non-squamous NSCLC
    Local Institution
    Springfield, Massachusetts
    Non-Squamous Cell Non-small Cell Lung Cancer
    The Study to Determine Safety, Tolerability and Pharmacokinetics of Oral Dabrafenib In Pediatric Subjects
    GSK Investigational Site
    Springfield, Massachusetts 01107
    Neoplasms, Brain
    Open-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+ Metastatic Breast Cancer
    Baystate Medical Center SC
    Springfield, Massachusetts 00119
    Hormone Receptor Positive Breast Cancer
    Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis
    Local Institution
    Springfield, Massachusetts
    Lupus Nephritis
    A Study of LY2940680 in Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Springfield, Massachusetts
    Small Cell Lung Carcinoma
    Phase 3 Study of Nivolumab or Nivolumab Plus Ipilimumab Versus Ipilimumab Alone in Previously Untreated Advanced Melanoma
    Local Institution
    Springfield, Massachusetts
    Unresectable or Metastatic Melanoma
    Comparison of ddI Versus Zidovudine in HIV-Infected Patients
    Baystate Med Ctr of Springfield
    Springfield, Massachusetts 01199
    HIV Infections
    Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission
    Baystate Regional Cancer Program at D'Amour Center for Cancer Care
    Springfield, Massachusetts 01199
    Leukemia
    Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer
    Baystate Medical Center
    Springfield, Massachusetts 01199
    Kidney Cancer
    Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed
    Baystate Medical Center
    Springfield, Massachusetts 01199
    Breast Cancer
    Combination Chemotherapy in Treating Children With Progressive Brain Tumors
    Baystate Regional Cancer Program at D'Amour Center for Cancer Care
    Springfield, Massachusetts 01199
    Brain and Central Nervous System Tumors
    Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
    Baystate Regional Cancer Program at Baystate Medical Center
    Springfield, Massachusetts 01107
    Sarcoma
    Combination Chemotherapy in Treating Children With Neuroblastoma
    Baystate Regional Cancer Program at D'Amour Center for Cancer Care
    Springfield, Massachusetts 01199
    Neuroblastoma
    Surgery in Treating Children With Neuroblastoma
    Baystate Regional Cancer Program at Baystate Medical Center
    Springfield, Massachusetts 01107
    Neuroblastoma
    Chemotherapy in Treating Children With Recurrent Acute Myeloid Leukemia
    Baystate Medical Center
    Springfield, Massachusetts 01199
    Leukemia
    Vinorelbine in Treating Children With Recurrent or Refractory Cancers
    Baystate Medical Center
    Springfield, Massachusetts 01199
    Brain and Central Nervous System Tumors, Neuroblastoma, Sarcoma
    Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer
    Baystate Medical Center
    Springfield, Massachusetts 01199
    Breast Cancer
    Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome
    Baystate Regional Cancer Program at Baystate Medical Center
    Springfield, Massachusetts 01107
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer
    Baystate Regional Cancer Program at D'Amour Center for Cancer Care
    Springfield, Massachusetts 01199
    Ovarian Cancer
    Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia
    Baystate Regional Cancer Program at D'Amour Center for Cancer Care
    Springfield, Massachusetts 01199
    Gestational Trophoblastic Tumor